Literature DB >> 89281

"Incessant ovulation" and ovarian cancer.

J T Casagrande, E W Louie, M C Pike, S Roy, R K Ross, B E Henderson.   

Abstract

A case-control study of 150 ovarian cancer patients under the age of 50 and individually matched controls was done to study the influence of fertility and oral contraceptive use on the risk of ovarian cancer. The risk decreased with increasing numbers of live births, with increasing numbers of incomplete pregnancies, and with the use of oral contraceptives. These three factors can be amalgamated into a single index of protection--"protected time"--by considering them all as periods of anovulation. The complement of protected time--viz., "ovulatory age", the period between menarche and diagnosis of ovarian cancer (or cessation of menses) minus "protected time"--was strongly related to risk of ovarian cancer. Other factors found to be associated with increased ovarian cancer risk were obesity, cervical polyps, and gallbladder disease. Women who had an "immediate" intolerance to oral contraceptive use had a fourfold increased risk of ovarian cancer. 7 patients, but no controls, could recall a family history of ovarian cancer.

Entities:  

Keywords:  Cancer; Case Studies; Contraception; Contraceptive Methods--side effects; Contraceptive Mode Of Action; Control Groups; Diseases; Family Planning; Gallbladder Diseases; High Risk Women; Neoplasms; Obesity; Oral Contraceptives--side effects; Ovarian Cancer; Ovulation Suppression; Reproduction; Research Methodology; Studies

Mesh:

Substances:

Year:  1979        PMID: 89281     DOI: 10.1016/s0140-6736(79)91435-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  77 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

3.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

Review 4.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

5.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

6.  Incomplete pregnancies and risk of ovarian cancer (Washington, United States).

Authors:  M T Chen; L S Cook; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

7.  Urban-rural differences of gynaecological malignancies in Egypt (1999-2002).

Authors:  S Dey; A Hablas; I A Seifeldin; K Ismail; M Ramadan; H El-Hamzawy; M L Wilson; M Banerjee; P Boffetta; J Harford; S D Merajver; A S Soliman
Journal:  BJOG       Date:  2009-12-16       Impact factor: 6.531

Review 8.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

9.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

10.  Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.

Authors:  Valerie McGuire; Patricia Hartge; Linda M Liao; Rashmi Sinha; Leslie Bernstein; Alison J Canchola; Garnet L Anderson; Marcia L Stefanick; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.